| Schedule of Listing expense |
The excess of fair value of TNL Mediagene ordinary
shares issued over the fair value of Blue Ocean’s identifiable net assets acquired represents compensation for the service of a
stock exchange listing for its shares and was expensed as incurred, the summary of which is as follows:
| | |
Listing expense | |
| | |
Shares | | |
Amount | |
| Fair value of TNL Mediagene equity consideration issued: | |
| | |
| |
| Public shareholders | |
| 3,195 | | |
$ | 685,040 | |
| Sponsor shareholders (Note 1) | |
| 136,321 | | |
| 29,227,201 | |
| Total value of TNL Mediagene shares issued to Blue Ocean shareholders (Note 2) | |
| | | |
| 29,912,241 | |
| Net assets of Blue Ocean as of December 5, 2024 | |
| | | |
| | |
| Cash and cash equivalents | |
| | | |
| 2,653 | |
| Financial assets at fair value through profit or loss | |
| | | |
| 741,839 | |
| Other payables | |
| | | |
| (5,396,683 | ) |
| Promissory notes | |
| | | |
| (2,562,102 | ) |
| Financial liabilities at fair value through profit or loss | |
| | | |
| (610,028 | ) |
| Other liabilities | |
| | | |
| (424,184 | ) |
| Total net assets of Blue Ocean as of December 5, 2024 | |
| | | |
| (8,248,505 | ) |
| Excess of fair value of TNL Mediagene consideration issued over Blue Ocean net assets acquired | |
| | | |
$ | 38,160,746 | |
|